|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | National Eye Institute (NEI) |
|---|---|
| Information provided by: | National Institutes of Health Clinical Center (CC) |
| ClinicalTrials.gov Identifier: | NCT00055029 |
Purpose
This study will explore the causes and eye problems of X-linked juvenile retinoschisis (XLRS), an inherited disease that causes vision loss primarily in young males. The vision loss, which worsens over time, is a result of schisis, or splitting, of the layers of the retina (tissue that lines the back of the eye). A better understanding of why and how XLRS develops might lead to improved treatments.
Patients 9 months of age and older with XLRS and females who are suspected carriers of the gene responsible for the disease (such as the mother of the patient) may be eligible for this study. Other family members of patients also may be enrolled.
Patients will undergo the following tests and procedures:
Family members will provide a blood sample for genetic study.
| Condition |
|---|
|
Retinoschisis |
| Study Type: | Observational |
| Official Title: | X-Linked Juvenile Retinoschisis - Clinical and Molecular Studies |
| Estimated Enrollment: | 500 |
| Study Start Date: | February 2003 |
| Estimated Primary Completion Date: | July 2006 (Final data collection date for primary outcome measure) |
Juvenile retinoschisis is an X-linked disease of retinal development caused by mutations in the XLRS1 gene. A rare condition, affecting 1:5000 to 1:25000 males worldwide, the disease is one of the more common causes of juvenile macular degeneration affecting boys. Affected individuals generally present with vision loss in early grade school. Schisis (splitting) of the nerve fiber layer is often seen clinically as a wheel like cystic formation in the macula in young patients. Peripheral schisis is reported in about 50% of the patients, predominantly in the inferotemporal part of the retina. Visual deterioration often progresses during the first 1 or 2 decades of life. The disease is mainly stable after puberty with slow progression continuing until the fifth or sixth decade. By the age of 40 to 50 years, macular degeneration often occurs, causing additional visual failure. In patients over 50 years of age macular pigmentary changes and retinal pigment epithelial (RPE) atrophy are common.
The objectives of this registry are to understand the nature of the XLRS disease in order to develop appropriate treatments by characterizing the anatomical and functional characteristics of retinoschisis and ultimately generate a well-documented genotype-phenotype correlation map. A minimum of 100 males diagnosed with X-linked retinoschisis will undergo clinical examination and have their blood drawn for genotyping. Blood will also be drawn from available and consenting mothers of affected males. An eye examination will be performed and blood drawn from any symptomatic available and consenting female family members. A maximum of 500 affected males and family members may be enrolled. Sites outside of NIH are participating as referral centers to accumulate the cohort.
Eligibility| Ages Eligible for Study: | 9 Months to 76 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Eligible participants must satisfy one of the criteria below.
Other unaffected relatives of probands, including both males and females.
EXCLUSION CRITERIA:
Affected males will be ineligible for participation if:
Are unable to cooperate with examination procedures without anesthesia
Both affected and unaffected individuals will be ineligible for participation if:
Contacts and Locations| Contact: Patient Recruitment and Public Liaison Office | (800) 411-1222 | prpl@mail.cc.nih.gov |
| Contact: TTY | 1-866-411-1010 |
| United States, Maryland | |
| National Institutes of Health Clinical Center, 9000 Rockville Pike | Recruiting |
| Bethesda, Maryland, United States, 20892 | |
More Information
| Study ID Numbers: | 030033, 03-EI-0033 |
| Study First Received: | February 15, 2003 |
| Last Updated: | September 9, 2009 |
| ClinicalTrials.gov Identifier: | NCT00055029 History of Changes |
| Health Authority: | United States: Federal Government |
|
Retinoschisis Genomic DNA Pedigree Analysis Genetic Analysis Macular Degeneration Juvenile Retinoschisis |
X-Linked Juvenile Retinoschisis XLRS Cone Dystrophy Juvenile Macular Degeneration Stargardt Syndrome |
|
Retinoschisis Eye Diseases Retinal Degeneration Retinal Diseases |